Common stock only | |
S&P 500 only | |
Director Only | |
10% Owner Only |
Trans Codes
Select...
Amount
-
Trade AUPH Insider Trades:
all
Unusual
Whales
Unusual Whales
Unusual Whales
Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
Director
10% Owner
Mcap/AUM
2025-05-16
2025-05-16
BAILEY JEFFREY ALLEN
A - Grant
Director Stock Option (right to buy)
37,485
$0.00
1
$1.08B
2025-05-16
2025-05-16
GOETZ KATHLEEN
A - Grant
Director Stock Option (right to buy)
63,724
$0.00
1
$1.08B
2025-05-16
2025-05-16
JOHNSON CRAIG
A - Grant
Director Stock Option (right to buy)
37,485
$0.00
1
$1.08B
2025-05-16
2025-05-16
NOVA TINA SUSAN
A - Grant
Director Stock Option (right to buy)
63,724
$0.00
1
$1.08B
2025-03-07
2025-03-07
KEENAN GREG
Chief Medical Officer
S - Sale
Common Stock
-8,305
$8.00
-66,440
1
$1.08B
2025-03-04
2025-03-04
ROBERTSON STEPHEN
EVP, General Counsel
S - Sale
Common Stock
-57,607
$8.00
-461K
1
$1.08B
2025-03-04
2025-03-04
DONLEY MATTHEW MAXWELL
Chief Operating Officer
S - Sale
Common Stock
-58,991
$8.00
-472K
1
$1.08B
2025-03-04
2025-03-04
GREENLEAF PETER
Chief Executive Officer
S - Sale
Common Stock
-165K
$8.00
-1.32M
1
$1.08B
2025-03-04
2025-03-04
MILLER JOSEPH
Chief Financial Officer
S - Sale
Common Stock
-56,154
$8.00
-449K
1
$1.08B
2025-03-03
2025-03-04
ROBERTSON STEPHEN
EVP, General Counsel
S - Sale
Common Stock
-64,872
$8.00
-519K
1
$1.08B
2025-03-03
2025-03-04
DONLEY MATTHEW MAXWELL
Chief Operating Officer
A - Grant
Common Stock
136K
$0.00
1
$1.08B
2025-03-03
2025-03-04
DONLEY MATTHEW MAXWELL
Chief Operating Officer
S - Sale
Common Stock
-65,902
$8.00
-527K
1
$1.08B
2025-03-03
2025-03-04
GREENLEAF PETER
Chief Executive Officer
S - Sale
Common Stock
-196K
$8.00
-1.56M
1
$1.08B
2025-03-03
2025-03-04
KEENAN GREG
Chief Medical Officer
S - Sale
Common Stock
-12,239
$8.00
-97,912
1
$1.08B
2025-03-03
2025-03-04
MILLER JOSEPH
Chief Financial Officer
S - Sale
Common Stock
-61,859
$8.00
-495K
1
$1.08B
2025-02-28
2025-03-04
DONLEY MATTHEW MAXWELL
Chief Operating Officer
A - Grant
Employee Stock Option (right to buy)
126K
$0.00
1
$1.08B
2025-02-28
2025-03-04
DONLEY MATTHEW MAXWELL
Chief Operating Officer
A - Grant
Common Stock
82,781
$0.00
1
$1.08B
2025-02-28
2025-03-04
GREENLEAF PETER
Chief Executive Officer
A - Grant
Employee Stock Option (right to buy)
444K
$0.00
1
$1.08B
2025-02-28
2025-03-04
KEENAN GREG
Chief Medical Officer
A - Grant
Employee Stock Option (right to buy)
95,570
$0.00
1
$1.08B
2025-02-28
2025-03-04
MILLER JOSEPH
Chief Financial Officer
A - Grant
Employee Stock Option (right to buy)
124K
$0.00
1
$1.08B
2025-02-28
2025-03-04
ROBERTSON STEPHEN
EVP, General Counsel
A - Grant
Employee Stock Option (right to buy)
128K
$0.00
1
$1.08B
2025-02-28
2025-03-04
ROBERTSON STEPHEN
EVP, General Counsel
A - Grant
Common Stock
84,106
$0.00
1
$1.08B
2024-11-21
2024-11-25
BAILEY JEFFREY ALLEN
A - Grant
Director Stock Option (right to buy)
18,641
$0.00
1
$1.08B
2024-11-21
2024-11-25
JAYNE DAVID R.W.
A - Grant
Director Stock Option (right to buy)
18,641
$0.00
1
$1.08B
2024-11-21
2024-11-25
JOHNSON CRAIG
A - Grant
Director Stock Option (right to buy)
31,688
$0.00
1
$1.08B
2024-11-21
2024-11-25
LEVERSAGE JILL
A - Grant
Director Stock Option (right to buy)
18,641
$0.00
1
$1.08B
2024-08-06
2024-08-08
HABIG SCOTT MICHAEL
Chief Commercial Officer
S - Sale
Common Stock
-18,249
$5.00
-91,245
1
$1.08B
2024-03-06
2024-03-07
DONLEY MATTHEW MAXWELL
EVP, Ops & Strategy
S - Sale
Common Stock
-40,665
$6.00
-244K
1
$1.08B
2024-03-06
2024-03-07
GREENLEAF PETER
Chief Executive Officer
S - Sale
Common Stock
-127K
$6.00
-762K
1
$1.08B
2024-03-06
2024-03-07
HABIG SCOTT MICHAEL
Chief Commercial Officer
S - Sale
Common Stock
-17,777
$6.00
-107K
1
$1.08B
2024-03-06
2024-03-07
MILLER JOSEPH
Chief Financial Officer
S - Sale
Common Stock
-34,811
$6.00
-209K
1
$1.08B
2024-03-06
2024-03-07
ROBERTSON STEPHEN
EVP, General Counsel
S - Sale
Common Stock
-57,745
$6.00
-346K
1
$1.08B
2024-02-27
2024-02-29
KNAPPERTZ VOLKER
EVP, Research and Development
S - Sale
Common Stock
-4,930
$6.00
-29,580
1
$1.08B
2024-02-20
2024-02-22
KNAPPERTZ VOLKER
EVP, Research and Development
S - Sale
Common Stock
-25,146
$5.00
-126K
1
$1.08B
2024-02-20
2024-02-22
HABIG SCOTT MICHAEL
Chief Commercial Officer
S - Sale
Common Stock
-15,867
$5.00
-79,335
1
$1.08B
2024-02-20
2024-02-22
DONLEY MATTHEW MAXWELL
EVP, Ops & Strategy
A - Grant
Common Stock
217K
$0.00
1
$1.08B
2024-02-20
2024-02-22
HABIG SCOTT MICHAEL
Chief Commercial Officer
A - Grant
Common Stock
196K
$0.00
1
$1.08B
2023-03-02
2024-02-22
MILLER JOSEPH
Chief Financial Officer
S - Sale
Common Stock
-11,398
$9.00
-103K
1
$1.08B
2023-03-02
2024-02-22
GREENLEAF PETER
Chief Executive Officer
S - Sale
Common Stock
-33,047
$9.00
-297K
1
$1.08B
2023-03-02
2024-02-22
ROBERTSON STEPHEN
EVP, General Counsel
S - Sale
Common Stock
-19,644
$9.00
-177K
1
$1.08B
2023-03-02
2023-03-06
KNAPPERTZ VOLKER
EVP, Research and Development
A - Grant
Common Stock
191K
$0.00
1
$1.08B
2023-03-02
2023-03-06
GREENLEAF PETER
Chief Executive Officer
S - Sale
Common Stock
-32,750
$9.00
-295K
1
$1.08B
2023-03-02
2023-03-06
MILLER JOSEPH
Chief Financial Officer
S - Sale
Common Stock
-11,296
$9.00
-102K
1
$1.08B
2023-03-02
2023-03-06
ROBERTSON STEPHEN
EVP, General Counsel
S - Sale
Common Stock
-19,402
$9.00
-175K
1
$1.08B
2022-11-21
2022-11-23
DONLEY MATTHEW MAXWELL
Ex VP, Internal Operations
P - Purchase
Common Stock
10,000
$5.00
50,000
1
$1.08B
2022-11-09
2022-11-14
HABIG SCOTT MICHAEL
Chief Commercial Officer
P - Purchase
Common Stock
5,000
$5.00
25,000
1
$1.08B
2022-11-07
2022-11-09
MARTIN MICHAEL ROBERT
Chief Business Officer
P - Purchase
Common Stock
30,000
$5.00
150K
1
$1.08B
2022-08-01
2022-08-01
HABIG SCOTT MICHAEL
Chief Commercial Officer
A - Grant
Restricted Stock Units
138K
$0.00
1
$1.08B
2022-08-01
2022-08-01
HABIG SCOTT MICHAEL
Chief Commercial Officer
A - Grant
Stock Option (right to buy)
231K
$0.00
1
$1.08B
2022-08-01
2022-08-01
KNAPPERTZ VOLKER
EVP, Research and Development
A - Grant
Restricted Stock Units
153K
$0.00
1
$1.08B
2022-08-01
2022-08-01
KNAPPERTZ VOLKER
EVP, Research and Development
A - Grant
Stock Option (right to buy)
257K
$0.00
1
$1.08B
2022-03-02
2022-03-04
COLAO MASSIMILANO
Chief Commercial Officer
A - Grant
Stock Option (right to buy)
178K
$0.00
1
$1.08B
2022-03-02
2022-03-04
COLAO MASSIMILANO
Chief Commercial Officer
A - Grant
Common Stock
8,500
$0.00
1
$1.08B
2022-03-02
2022-03-04
DONLEY MATTHEW MAXWELL
Ex VP, Intern'l Operations
A - Grant
Restricted Stock Unit
104K
$0.00
1
$1.08B
2022-03-02
2022-03-04
DONLEY MATTHEW MAXWELL
Ex VP, Intern'l Operations
A - Grant
Stock Option (right to buy)
178K
$0.00
1
$1.08B
2022-03-02
2022-03-04
DONLEY MATTHEW MAXWELL
Ex VP, Intern'l Operations
A - Grant
Common Stock
8,500
$0.00
1
$1.08B
2022-03-02
2022-03-04
GREENLEAF PETER
Chief Executive Officer
A - Grant
Restricted Stock Unit
312K
$0.00
1
$1.08B
2022-03-02
2022-03-04
GREENLEAF PETER
Chief Executive Officer
A - Grant
Stock Option (right to buy)
534K
$0.00
1
$1.08B
2022-03-02
2022-03-04
GREENLEAF PETER
Chief Executive Officer
A - Grant
Common Stock
28,300
$0.00
1
$1.08B
2022-03-02
2022-03-04
HUIZINGA ROBERT BINDERT
EVP of Research
A - Grant
Restricted Stock Unit
62,448
$0.00
1
$1.08B
2022-03-02
2022-03-04
HUIZINGA ROBERT BINDERT
EVP of Research
A - Grant
Stock Option (right to buy)
107K
$0.00
1
$1.08B
2022-03-02
2022-03-04
HUIZINGA ROBERT BINDERT
EVP of Research
A - Grant
Common Stock
8,500
$0.00
1
$1.08B
2022-03-02
2022-03-04
MARTIN MICHAEL ROBERT
Chief Business Officer
A - Grant
Stock Option (right to buy)
107K
$0.00
1
$1.08B
2022-03-02
2022-03-04
MARTIN MICHAEL ROBERT
Chief Business Officer
A - Grant
Common Stock
8,500
$0.00
1
$1.08B
2022-03-02
2022-03-04
MILLER JOSEPH
Chief Financial Officer
A - Grant
Restricted Stock Unit
104K
$0.00
1
$1.08B
2022-03-02
2022-03-04
MILLER JOSEPH
Chief Financial Officer
A - Grant
Stock Option (right to buy)
178K
$0.00
1
$1.08B
2022-03-02
2022-03-04
ROBERTSON STEPHEN
EVP, General Counsel
A - Grant
Restricted Stock Unit
104K
$0.00
1
$1.08B
2022-03-02
2022-03-04
ROBERTSON STEPHEN
EVP, General Counsel
A - Grant
Stock Option (right to buy)
178K
$0.00
1
$1.08B
2022-03-02
2022-03-04
SOLOMONS NEIL
Chief Medical Officer
A - Grant
Restricted Stock Unit
72,856
$0.00
1
$1.08B
2022-03-02
2022-03-04
SOLOMONS NEIL
Chief Medical Officer
A - Grant
Stock Option (right to buy)
125K
$0.00
1
$1.08B
2022-03-02
2022-03-04
COLAO MASSIMILANO
Chief Commercial Officer
S - Sale
Common Stock
-3,205
$12.00
-38,460
1
$1.08B
2022-03-02
2022-03-04
DONLEY MATTHEW MAXWELL
Ex VP, Intern'l Operations
S - Sale
Common Stock
-3,052
$12.00
-36,624
1
$1.08B
2022-03-02
2022-03-04
GREENLEAF PETER
Chief Executive Officer
S - Sale
Common Stock
-9,068
$12.00
-109K
1
$1.08B
2022-03-02
2022-03-04
HUIZINGA ROBERT BINDERT
EVP of Research
S - Sale
Common Stock
-4,849
$12.00
-58,188
1
$1.08B
2022-03-02
2022-03-04
MARTIN MICHAEL ROBERT
Chief Business Officer
S - Sale
Common Stock
-4,849
$12.00
-58,188
1
$1.08B
2022-03-02
2022-03-04
MILLER JOSEPH
Chief Financial Officer
S - Sale
Common Stock
-3,060
$12.00
-36,720
1
$1.08B
2022-03-02
2022-03-04
SOLOMONS NEIL
Chief Medical Officer
S - Sale
Common Stock
-4,846
$12.00
-58,152
1
$1.08B
2022-03-02
2022-03-04
MARTIN MICHAEL ROBERT
Chief Business Officer
A - Grant
Restricted Stock Unit
62,448
$0.00
1
$1.08B
2022-03-02
2022-03-04
COLAO MASSIMILANO
Chief Commercial Officer
A - Grant
Restricted Stock Unit
104K
$0.00
1
$1.08B
2021-11-11
2021-11-12
MARTIN MICHAEL ROBERT
Chief Business Officer
M - Exercise
Common Stock
29,000
$18.00
522K
1
$1.08B
2021-11-11
2021-11-12
MARTIN MICHAEL ROBERT
Chief Business Officer
M - Exercise
Stock Option (right to buy)
-29,000
$0.00
1
$1.08B
2021-11-11
2021-11-12
SOLOMONS NEIL
Chief Medical Officer
M - Exercise
Stock Option (right to buy)
-100K
$0.00
1
$1.08B
2021-11-11
2021-11-12
SOLOMONS NEIL
Chief Medical Officer
M - Exercise
Common Stock
100K
$5.00
500K
1
$1.08B
2021-11-11
2021-11-12
MARTIN MICHAEL ROBERT
Chief Business Officer
S - Sale
Common Shares
-11,000
$30.00
-330K
1
$1.08B
2021-11-11
2021-11-12
MARTIN MICHAEL ROBERT
Chief Business Officer
S - Sale
Common Stock
-29,000
$29.00
-841K
1
$1.08B
2021-11-11
2021-11-12
SOLOMONS NEIL
Chief Medical Officer
S - Sale
Common Stock
-100K
$29.00
-2.90M
1
$1.08B
2021-11-10
2021-11-12
SOLOMONS NEIL
Chief Medical Officer
M - Exercise
Stock Option (right to buy)
-100K
$0.00
2
$1.08B
2021-11-10
2021-11-12
SOLOMONS NEIL
Chief Medical Officer
S - Sale
Common Stock
-100K
$31.00
-3.10M
2
$1.08B
2021-11-10
2021-11-12
MARTIN MICHAEL ROBERT
Chief Business Officer
S - Sale
Common Shares
-60,000
$31.00
-1.86M
2
$1.08B
2021-11-10
2021-11-12
SOLOMONS NEIL
Chief Medical Officer
M - Exercise
Common Stock
100K
$6.00
600K
2
$1.08B
2021-11-09
2021-11-12
MARTIN MICHAEL ROBERT
Chief Business Officer
S - Sale
Common Shares
-50,000
$30.00
-1.50M
1
$1.08B
2021-11-09
2021-11-12
SOLOMONS NEIL
Chief Medical Officer
S - Sale
Common Shares
-50,000
$30.00
-1.50M
1
$1.08B
2021-11-01
2021-11-03
MARTIN MICHAEL ROBERT
Chief Business Officer
M - Exercise
Stock Option (right to buy)
-45,000
$0.00
1
$1.08B
2021-11-01
2021-11-03
MARTIN MICHAEL ROBERT
Chief Business Officer
S - Sale
Common Stock
-45,000
$32.00
-1.44M
1
$1.08B
2021-11-01
2021-11-03
SOLOMONS NEIL
Chief Medical Officer
M - Exercise
Common Stock
45,000
$5.00
225K
1
$1.08B
2021-11-01
2021-11-03
SOLOMONS NEIL
Chief Medical Officer
M - Exercise
Stock Option (right to buy)
-45,000
$0.00
1
$1.08B
2021-11-01
2021-11-03
MARTIN MICHAEL ROBERT
Chief Business Officer
M - Exercise
Common Stock
45,000
$3.00
135K
1
$1.08B
2021-11-01
2021-11-03
SOLOMONS NEIL
Chief Medical Officer
S - Sale
Common Stock
-45,000
$32.00
-1.44M
1
$1.08B
2021-10-25
2021-10-26
HUIZINGA ROBERT BINDERT
EVP of Research
S - Sale
Common Stock
-130K
$30.00
-3.90M
1
$1.08B
2021-10-25
2021-10-26
HUIZINGA ROBERT BINDERT
EVP of Research
M - Exercise
Stock Option (right to buy)
-95,000
$0.00
1
$1.08B
2021-10-25
2021-10-26
HUIZINGA ROBERT BINDERT
EVP of Research
M - Exercise
Common Stock
95,000
$3.00
285K
1
$1.08B
2021-09-21
2021-09-22
MARTIN MICHAEL ROBERT
Chief Business Officer
M - Exercise
Common Stock
87,500
$7.00
613K
3
$1.08B
2021-09-21
2021-09-22
HUIZINGA ROBERT BINDERT
EVP of Research
S - Sale
Common Stock
-32,500
$24.00
-780K
2
$1.08B
2021-09-21
2021-09-22
MARTIN MICHAEL ROBERT
Chief Business Officer
S - Sale
Common Shares
-87,500
$24.00
-2.10M
1
$1.08B
2021-09-21
2021-09-22
HUIZINGA ROBERT BINDERT
EVP of Research
M - Exercise
Stock Option (right to buy)
-27,136
$0.00
2
$1.08B
2021-09-21
2021-09-22
HUIZINGA ROBERT BINDERT
EVP of Research
M - Exercise
Common Stock
27,136
$3.00
81,408
2
$1.08B
2021-09-21
2021-09-22
MARTIN MICHAEL ROBERT
Chief Business Officer
M - Exercise
Option Grant (right to buy)
-87,500
$0.00
3
$1.08B
2021-09-20
2021-09-22
MARTIN MICHAEL ROBERT
Chief Business Officer
M - Exercise
Common Stock
28,500
$5.00
143K
1
$1.08B
2021-09-20
2021-09-22
MARTIN MICHAEL ROBERT
Chief Business Officer
S - Sale
Common Shares
-28,500
$22.00
-627K
2
$1.08B
2021-09-20
2021-09-22
MARTIN MICHAEL ROBERT
Chief Business Officer
M - Exercise
Option Grant (right to buy)
-28,500
$5.00
-143K
1
$1.08B
2021-09-14
2021-09-16
MARTIN MICHAEL ROBERT
Chief Business Officer
M - Exercise
Option Grant (right to buy)
-44,000
$0.00
1
$1.08B
2021-09-14
2021-09-16
MARTIN MICHAEL ROBERT
Chief Business Officer
M - Exercise
Common Stock
44,000
$5.00
220K
1
$1.08B
2021-09-14
2021-09-16
MARTIN MICHAEL ROBERT
Chief Business Officer
S - Sale
Common Shares
-44,000
$22.00
-968K
2
$1.08B
2021-09-14
2021-09-14
MARTIN MICHAEL ROBERT
Chief Business Officer
M - Exercise
Option Grant (right to buy)
-90,000
$0.00
2
$1.08B
2021-09-14
2021-09-14
HUIZINGA ROBERT BINDERT
EVP of Research
S - Sale
Common Stock
-22,500
$22.00
-495K
1
$1.08B
2021-09-14
2021-09-14
MARTIN MICHAEL ROBERT
Chief Business Officer
S - Sale
Common Stock
-90,000
$21.00
-1.89M
1
$1.08B
2021-09-14
2021-09-14
MARTIN MICHAEL ROBERT
Chief Business Officer
M - Exercise
Common Stock
90,000
$4.00
360K
2
$1.08B
2021-09-13
2021-09-14
MARTIN MICHAEL ROBERT
Chief Business Officer
M - Exercise
Common Shares
25,000
$5.00
125K
1
$1.08B
2021-09-13
2021-09-14
SOLOMONS NEIL
Chief Medical Officer
M - Exercise
Stock Option (right to buy)
-150K
$0.00
1
$1.08B
2021-09-13
2021-09-14
SOLOMONS NEIL
Chief Medical Officer
M - Exercise
Common Shares
150K
$3.00
450K
1
$1.08B
2021-09-13
2021-09-14
MARTIN MICHAEL ROBERT
Chief Business Officer
M - Exercise
Option Grant (right to buy)
-25,000
$0.00
1
$1.08B
2021-09-10
2021-09-14
SOLOMONS NEIL
Chief Medical Officer
S - Sale
Common Shares
-150K
$20.00
-3.00M
1
$1.08B
2021-09-10
2021-09-14
HUIZINGA ROBERT BINDERT
EVP of Research
S - Sale
Common Stock
-10,000
$20.00
-200K
2
$1.08B
2021-09-10
2021-09-14
MARTIN MICHAEL ROBERT
Chief Business Officer
S - Sale
Common Shares
-25,000
$20.00
-500K
1
$1.08B
2021-09-07
2021-09-08
HUIZINGA ROBERT BINDERT
EVP of Research
S - Sale
Common Stock
-5,000
$18.00
-90,000
1
$1.08B
2021-09-07
2021-09-08
MARTIN MICHAEL ROBERT
Chief Business Officer
S - Sale
Common Stock
-7,500
$18.00
-135K
1
$1.08B
2021-08-26
2021-08-27
MARTIN MICHAEL ROBERT
Chief Business Officer
S - Sale
Common Stock
-22,500
$18.00
-405K
1
$1.08B
2021-08-25
2021-08-26
SOLOMONS NEIL
Chief Medical Officer
S - Sale
Common Stock
-5,000
$16.00
-80,000
1
$1.08B
2021-08-09
2021-08-10
MARTIN MICHAEL ROBERT
Chief Business Officer
S - Sale
Common Stock
-5,000
$16.00
-80,000
1
$1.08B
2021-08-09
2021-08-10
SOLOMONS NEIL
Chief Medical Officer
S - Sale
Common Stock
-45,000
$16.00
-720K
1
$1.08B
2021-07-28
2021-07-29
MARTIN MICHAEL ROBERT
Chief Business Officer
S - Sale
Common Stock
-5,000
$14.00
-70,000
1
$1.08B
2021-06-22
2021-06-23
MARTIN MICHAEL ROBERT
Chief Business Officer
S - Sale
Common Stock
-5,000
$14.00
-70,000
1
$1.08B
2021-05-11
2021-05-12
GREENLEAF PETER
Chief Executive Officer
P - Purchase
Common Stock
5,125
$11.00
56,375
2
$1.08B
2021-05-11
2021-05-12
MARTIN MICHAEL ROBERT
Chief Business Officer
M - Exercise
Option Grant (right to buy)
-20,000
$0.00
1
$1.08B
2021-05-11
2021-05-12
MARTIN MICHAEL ROBERT
Chief Business Officer
M - Exercise
Common Stock
20,000
$3.00
60,000
1
$1.08B
2021-05-11
2021-05-12
DONLEY MATTHEW MAXWELL
Ex VP, Intern'l Operations
P - Purchase
Common Stock
9,900
$10.00
99,000
1
$1.08B
2021-05-11
2021-05-11
HUIZINGA ROBERT BINDERT
Ex Vice President of Research
M - Exercise
Stock Option (right to buy)
-40,000
$0.00
1
$1.08B
2021-05-11
2021-05-11
HUIZINGA ROBERT BINDERT
Ex Vice President of Research
M - Exercise
Common Stock
40,000
$3.00
120K
1
$1.08B
2021-05-11
2021-05-11
MILLER JOSEPH
Chief Financial Officer
P - Purchase
Common Stock
1,000
$10.00
10,000
1
$1.08B
2021-03-12
2021-03-15
SOLOMONS NEIL
Chief Medical Officer
M - Exercise
Stock Option (right to buy)
-40,000
$0.00
1
$1.08B
2021-03-12
2021-03-15
SOLOMONS NEIL
Chief Medical Officer
M - Exercise
Common Stock
40,000
$3.00
120K
1
$1.08B
2021-03-12
2021-03-15
SOLOMONS NEIL
Chief Medical Officer
S - Sale
Common Stock
-40,000
$13.00
-520K
1
$1.08B
2021-01-28
2021-01-29
ROBERTSON STEPHEN
EVP, General Counsel
P - Purchase
Common Stock
900
$16.00
14,400
1
$1.08B